These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


593 related items for PubMed ID: 14666426

  • 1. DNA vaccines for cancer.
    Boyd D, Hung CF, Wu TC.
    IDrugs; 2003 Dec; 6(12):1155-64. PubMed ID: 14666426
    [Abstract] [Full Text] [Related]

  • 2. Improving DNA vaccine potency via modification of professional antigen presenting cells.
    Hung CF, Wu TC.
    Curr Opin Mol Ther; 2003 Feb; 5(1):20-4. PubMed ID: 12669466
    [Abstract] [Full Text] [Related]

  • 3. Modifying professional antigen-presenting cells to enhance DNA vaccine potency.
    Hung CF, Yang M, Wu TC.
    Methods Mol Med; 2006 Feb; 127():199-220. PubMed ID: 16988456
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. DNA gene fusion vaccines against cancer.
    Zhu D, Stevenson FK.
    Curr Opin Mol Ther; 2002 Feb; 4(1):41-8. PubMed ID: 11883694
    [Abstract] [Full Text] [Related]

  • 8. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D, Moyana T, Xiang J.
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [Abstract] [Full Text] [Related]

  • 9. DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
    Stevenson FK, Rice J, Ottensmeier CH, Thirdborough SM, Zhu D.
    Immunol Rev; 2004 Jun; 199():156-80. PubMed ID: 15233733
    [Abstract] [Full Text] [Related]

  • 10. New trends in the development of cancer vaccines.
    Minev BR, Chavez FL, Mitchell MS.
    In Vivo; 1998 Jun; 12(6):629-38. PubMed ID: 9891226
    [Abstract] [Full Text] [Related]

  • 11. DNA vaccines: an historical perspective and view to the future.
    Liu MA.
    Immunol Rev; 2011 Jan; 239(1):62-84. PubMed ID: 21198665
    [Abstract] [Full Text] [Related]

  • 12. Current developments in cancer vaccines and cellular immunotherapy.
    Ribas A, Butterfield LH, Glaspy JA, Economou JS.
    J Clin Oncol; 2003 Jun 15; 21(12):2415-32. PubMed ID: 12805342
    [Abstract] [Full Text] [Related]

  • 13. Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens.
    Pavlenko M, Leder C, Pisa P.
    Expert Rev Vaccines; 2005 Jun 15; 4(3):315-27. PubMed ID: 16026247
    [Abstract] [Full Text] [Related]

  • 14. The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.
    Lynch DH.
    Immunol Rev; 2008 Apr 15; 222():277-86. PubMed ID: 18364008
    [Abstract] [Full Text] [Related]

  • 15. Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy.
    Li Y, Subjeck J, Yang G, Repasky E, Wang XY.
    Vaccine; 2006 Jun 19; 24(25):5360-70. PubMed ID: 16714072
    [Abstract] [Full Text] [Related]

  • 16. Cancer immunotherapy.
    Baxevanis CN, Perez SA, Papamichail M.
    Crit Rev Clin Lab Sci; 2009 Jun 19; 46(4):167-89. PubMed ID: 19650714
    [Abstract] [Full Text] [Related]

  • 17. DNA vaccines against cancer.
    Stan R, Wolchok JD, Cohen AD.
    Hematol Oncol Clin North Am; 2006 Jun 19; 20(3):613-36. PubMed ID: 16762727
    [Abstract] [Full Text] [Related]

  • 18. Cell fusion: from hybridoma to dendritic cell-based vaccine.
    Gong J, Koido S, Calderwood SK.
    Expert Rev Vaccines; 2008 Sep 19; 7(7):1055-68. PubMed ID: 18767954
    [Abstract] [Full Text] [Related]

  • 19. Cancer vaccines: between the idea and the reality.
    Finn OJ.
    Nat Rev Immunol; 2003 Aug 19; 3(8):630-41. PubMed ID: 12974478
    [Abstract] [Full Text] [Related]

  • 20. Poxviruses as vectors for cancer immunotherapy.
    Kwak H, Hörig H, Kaufman HL.
    Curr Opin Drug Discov Devel; 2003 Mar 19; 6(2):161-8. PubMed ID: 12669450
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.